Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management
This Special Issue contributes original research and review articles on the role of new protein, molecular, and genetic markers used for the diagnosis and progression of civilization diseases, as well as biomarkers useful in the monitoring the effects of the implemented treatment.
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_80955 | ||
| 005 | 20220506 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20220506s2022 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-3745-0 | ||
| 020 | |a 9783036537467 | ||
| 020 | |a 9783036537450 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-3745-0 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 100 | 1 | |a Komosinska-Vassev, Katarzyna |4 edt | |
| 700 | 1 | |a Olczyk, Pawel |4 edt | |
| 700 | 1 | |a Komosinska-Vassev, Katarzyna |4 oth | |
| 700 | 1 | |a Olczyk, Pawel |4 oth | |
| 245 | 1 | 0 | |a Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 electronic resource (208 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This Special Issue contributes original research and review articles on the role of new protein, molecular, and genetic markers used for the diagnosis and progression of civilization diseases, as well as biomarkers useful in the monitoring the effects of the implemented treatment. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 653 | |a pharmacogenomics | ||
| 653 | |a NGS variants | ||
| 653 | |a personalized medicine | ||
| 653 | |a FSHR | ||
| 653 | |a personalized drug therapy | ||
| 653 | |a hedgehog-interacting protein | ||
| 653 | |a impaired fasting glucose | ||
| 653 | |a impaired glucose tolerance | ||
| 653 | |a newly diagnosed diabetes | ||
| 653 | |a normal glucose tolerance | ||
| 653 | |a inflammatory bowel disease | ||
| 653 | |a ulcerative colitis | ||
| 653 | |a Crohn's disease | ||
| 653 | |a extracellular matrix components | ||
| 653 | |a hyaluronan | ||
| 653 | |a inflammatory bowel diseases (IBD) | ||
| 653 | |a Crohn's disease (CD) | ||
| 653 | |a ulcerative colitis (UC) | ||
| 653 | |a sulfated glycosaminoglycans (sGAG) | ||
| 653 | |a hyaluronan (HA) | ||
| 653 | |a soluble part of syndecan-1 (sCD138) | ||
| 653 | |a microRNA | ||
| 653 | |a cardiovascular disease | ||
| 653 | |a diabetes | ||
| 653 | |a mortality | ||
| 653 | |a antiplatelet therapy | ||
| 653 | |a platelet reactivity | ||
| 653 | |a Let-7e | ||
| 653 | |a miR-126 | ||
| 653 | |a miR-223 | ||
| 653 | |a miR-125a-3p | ||
| 653 | |a CCL11 | ||
| 653 | |a CCL24 | ||
| 653 | |a CCL26 | ||
| 653 | |a CCR3 | ||
| 653 | |a CRC | ||
| 653 | |a adiponectin | ||
| 653 | |a adipokines | ||
| 653 | |a rheumatology | ||
| 653 | |a obesity | ||
| 653 | |a overweight | ||
| 653 | |a case control study | ||
| 653 | |a rheumatoid arthritis | ||
| 653 | |a TNF-α inhibitors | ||
| 653 | |a bone turnover markers | ||
| 653 | |a PINP | ||
| 653 | |a PICP | ||
| 653 | |a NTX-I | ||
| 653 | |a CTX-I | ||
| 653 | |a RANKL/OPG | ||
| 653 | |a ovarian cancer | ||
| 653 | |a interleukin 21 | ||
| 653 | |a interleukin 22 | ||
| 653 | |a lymphocytes | ||
| 653 | |a macrophages | ||
| 653 | |a dendritic cells | ||
| 653 | |a innate lymphoid cells | ||
| 653 | |a breast cancer | ||
| 653 | |a extracellular matrix | ||
| 653 | |a proteins | ||
| 653 | |a tumorigenesis | ||
| 653 | |a tumor microenvironment | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/5293 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/80955 |7 0 |z DOAB: description of the publication |